Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Is Right Atrial Remodeling an Additional Marker for the Progression of Atrial Fibrillation?

Park JK

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Trends and Movements in Managing Pulmonary Arterial Hypertension in Korea

Seung J, Park HJ

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Novel Transthyretin Gene Mutation in Hereditary Transthyretin Amyloidosis: A Case Series of Met13dup Patients

Jeon K, Kim D, Park M, Choi JO, Kim K, Kim SJ, Kim JS, Jeon ES

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pearls and Pitfalls of Pulsed Field Ablation

Hartl S, Reinsch N, Füting A, Neven K

Pulsed field ablation (PFA) was recently rediscovered as an emerging treatment modality for the ablation of cardiac arrhythmias. Ultra-short high voltage pulses are leading to irreversible electroporation of cardiac cells...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Strategies of Improving Quality of Care in Patients With Heart Failure

Kim SE, Yoo BS

Heart failure (HF) is a global health problem closely related to morbidity and mortality. As the burden of HF increases, it is necessary to manage and treat this condition well....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Impact of Right Atrial Size to Predict Success of Direct Current Cardioversion in Patients With Persistent Atrial Fibrillation

Döring C, Richter U, Ulbrich S, Wunderlich C, Ebert M, Richter S, Linke A, Sveric KM

Background and Objectives: The prognostic implication of right atrial (RA) and left atrial (LA) size for an immediate success of direct current cardioversion (DCCV) in atrial fibrillation (AF) remains unclear....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidemiology of PAH in Korea: An Analysis of the National Health Insurance Data, 2002–2018

Jang AY, Lee HH, Lee H, Kim HC, Chung WJ

Background and Objectives: Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Recent advances in PAH-specific drugs have improved its outcomes, although the healthcare burden of novel therapeutics may...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr